Targeting Cdk11 in osteosarcoma cells using the CRISPR‐cas9 systemYong Feng, Zhenfeng Duan|Journal of Orthopaedic Research®|2014Cited by 106
Targeting <i>ABCB1 (MDR1)</i> in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistanceTang Liu, Zhenfeng Duan|Oncotarget|2016Cited by 88
The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancerYubing Zhou, Zhenfeng Duan|Oncotarget|2016Cited by 74
SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear TranslocationZhenfeng Duan, Michael V. Seiden|Clinical Cancer Research|2006Cited by 67
Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcomaRan Wei, Zhenfeng Duan|Journal of Orthopaedic Research®|2020Cited by 30